Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.1 - $12.82 $94,096 - $169,903
-13,253 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$7.64 - $12.49 $101,230 - $165,492
-13,250 Reduced 49.99%
13,253 $146,000
Q1 2021

May 17, 2021

SELL
$12.0 - $27.64 $40,644 - $93,616
-3,387 Reduced 11.33%
26,503 $403,000
Q2 2020

Aug 12, 2020

BUY
$9.75 - $17.6 $10,530 - $19,008
1,080 Added 3.75%
29,890 $446,000
Q2 2019

Aug 12, 2019

BUY
$3.77 - $8.67 $50,046 - $115,094
13,275 Added 85.45%
28,810 $241,000
Q2 2018

Aug 13, 2018

BUY
$0.92 - $3.5 $3,896 - $14,822
4,235 Added 37.48%
15,535 $14,000
Q4 2017

Feb 12, 2018

BUY
$1.63 - $2.0 $18,419 - $22,600
11,300
11,300 $21,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $52.5M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.